SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-17-011148
Filing Date
2017-02-23
Accepted
2017-02-23 14:47:52
Documents
3
Group Members
ATLAS VENTURE ASSOCIATES VII, INC.ATLAS VENTURE ASSOCIATES VII, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D a17-7111_1sc13d.htm SC 13D 105939
2 EX-99.1 a17-7111_1ex99d1.htm EX-99.1 14746
3 EX-99.2 a17-7111_1ex99d2.htm EX-99.2 28153
  Complete submission text file 0001104659-17-011148.txt   150594
Mailing Address 890 WINTER STREET WALTHAM MA 02451
Business Address 890 WINTER STREET WALTHAM MA 02451 7816221700
Atlas Venture Fund VII L P (Filed by) CIK: 0001346450 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D

Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Subject) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88625 | Film No.: 17631932
SIC: 8071 Services-Medical Laboratories